The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy

被引：0
|
作者：
Federico Spandonaro
Fabio Ayala
Enzo Berardesca
Sergio Chimenti
Giampiero Girolomoni
Patrizia Martini
Andrea Peserico
Barbara Polistena
Antonio Puglisi Guerra
Gino Antonio Vena
Gianfranco Altomare
Piergiacomo Calzavara Pinton
机构：
[1] University of Rome Tor Vergata,Department of Dermatology
[2] University of Naples Federico II,Department of Dermatology
[3] San Gallicano Dermatological Institute,Department of Medicine, Section of Dermatology and Venereology
[4] University of Rome “Tor Vergata”,Unit of Dermatology
[5] University of Verona,Unit of Dermatology, Department of Medicine
[6] Lucca Hospital,Department of Dermatology
[7] University of Padua,Department of Dermatology
[8] Messina Hospital,Department of Dermatology
[9] Dermatology and Venereology Private Practice,undefined
[10] Dermatology and Venereology Private Practice,undefined
[11] IRCCS Galeazzi Orthopedic Institute,undefined
[12] Spedali Civili,undefined
来源：
BioDrugs | 2014年 / 28卷
关键词：
Psoriasis; Infliximab; Etanercept; Adalimumab; Health Technology Assessment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：285 / 295
页数：10
相关论文
共 50 条
  • [21] The impact of biologic therapy in chronic plaque psoriasis from a societal perspective: an analysis based on Italian actual clinical practice
    Polistena, B.
    Calzavara-Pinton, P.
    Altomare, G.
    Berardesca, E.
    Girolomoni, G.
    Martini, P.
    Peserico, A.
    Guerra, A. Puglisi
    Spandonaro, F.
    Gino, A. Vena
    Chimenti, S.
    Ayala, F.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (12) : 2411 - 2416
  • [22] Treatment patterns and therapy effectiveness in psoriasis patients initiating biologic therapy in England
    Khalid, Javaria Mona
    Fox, Kathleen M.
    Globe, Gary
    Maguire, Andrew
    Chau, Dina
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2014, 25 (01) : 67 - 72
  • [23] Biologic Therapies for Chronic Plaque Psoriasis and Cardiovascular Events
    Tzellos, Thrasivoulos
    Kyrgidis, Athanassios
    Toulis, Konstantinos
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (19): : 2095 - 2095
  • [24] From biologic to biologic to biologic: Lessons to learn for erythrodermic and recalcitrant chronic plaque psoriasis
    Yip, Leona
    Harrison, Shannon
    Foley, Peter
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2008, 49 (03) : 152 - 155
  • [25] A Review of Neurologic Complications of Biologic Therapy in Plaque Psoriasis
    Lin, Elaine J.
    Reddy, Shivani
    Shah, Vidhi V.
    Wu, Jashin J.
    CUTIS, 2018, 101 (01): : 57 - 60
  • [26] Impact of previous biologic use and body weight on the effectiveness of guselkumab in moderate-to-severe plaque psoriasis: a real-world practice
    Hung, Yi-Teng
    Lin, Yu-, Jr.
    Chiu, Hsien-Yi
    Huang, Yu-Huei
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021, 12
  • [27] COST-EFFECTIVENESS OF BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN GERMANY
    Betts, K.
    Yan, Y.
    Sundaram, M.
    Hengst, N.
    Wolff, M.
    Bensimon, A. G.
    VALUE IN HEALTH, 2012, 15 (07) : A570 - A570
  • [28] Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis
    Francesco Bellinato
    Paolo Gisondi
    Elena Mason
    Paolo Ricci
    Martina Maurelli
    Giampiero Girolomoni
    Dermatology and Therapy, 2022, 12 : 1303 - 1311
  • [29] Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis
    Bellinato, Francesco
    Gisondi, Paolo
    Mason, Elena
    Ricci, Paolo
    Maurelli, Martina
    Girolomoni, Giampiero
    DERMATOLOGY AND THERAPY, 2022, 12 (06) : 1303 - 1311
  • [30] Cost-effectiveness and comparative effectiveness of biologic therapy for asthma To biologic or not to biologic?
    Anderson, William C., III
    Szefler, Stanley J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 122 (04) : 367 - 372
12345